Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,755 | 61,694 | 67,112 | 33,328 | 33,060 |
| Receivables | N/A | N/A | N/A | N/A | 556 |
| TOTAL | $59,323 | $62,441 | $67,337 | $33,691 | $34,015 |
| Non-Current Assets | |||||
| PPE Net | 453 | 493 | 539 | 571 | 591 |
| Intangibles | 19,092 | 19,092 | 19,092 | 19,092 | 19,092 |
| Other Non-Current Assets | 524 | 572 | 449 | 497 | 544 |
| TOTAL | $20,069 | $20,157 | $20,080 | $20,160 | $20,227 |
| Total Assets | $79,392 | $82,598 | $87,417 | $53,851 | $54,242 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,297 | 961 | 2,138 | 1,194 | 1,080 |
| Other current liabilities | 12 | 34 | 51 | 60 | 61 |
| TOTAL | $1,545 | $1,228 | $2,379 | $1,457 | $1,358 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 291 | 344 | 269 | 308 | 345 |
| TOTAL | $298 | $358 | $290 | $336 | $379 |
| Total Liabilities | $1,843 | $1,586 | $2,669 | $1,793 | $1,737 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,119 | 8,119 | 8,119 | 8,119 | 5,953 |
| Common Shares | 8 | 98 | 98 | 72 | 71 |
| Retained earnings | -259,093 | -255,408 | -251,467 | -247,646 | -244,908 |
| TOTAL | $77,549 | $81,012 | $84,748 | $52,058 | $52,505 |
| Total Liabilities And Equity | $79,392 | $82,598 | $87,417 | $53,851 | $54,242 |